Since elevated levels of Trx-1 are associated with tumor progression the increase of TXNIP protein was associated with a higher overall survival of patients with mammary carcinomas [50] suggesting that TXNIP could inhibit tumor progression [49]. This evidence concerns the gene TXN and neoplasm.